Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
about
Integrating modern concepts of insomnia and its contemporary treatment into primary care.Orexin receptor antagonists--a patent review (2010 to August 2014).Small-molecule antagonists of the orexin receptors.Orexin OX2 Receptor Antagonists as Sleep Aids.Structure-activity relationship, biological, and pharmacological characterization of the proline sulfonamide ACT-462206: a potent, brain-penetrant dual orexin 1/orexin 2 receptor antagonist.Orexin Receptor Antagonists
P2860
Entry-into-humans study with ACT-462206, a novel dual orexin receptor antagonist, comparing its pharmacodynamics with almorexant
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Entry-into-humans study with A ...... armacodynamics with almorexant
@ast
Entry-into-humans study with A ...... armacodynamics with almorexant
@en
Entry-into-humans study with A ...... armacodynamics with almorexant
@nl
type
label
Entry-into-humans study with A ...... armacodynamics with almorexant
@ast
Entry-into-humans study with A ...... armacodynamics with almorexant
@en
Entry-into-humans study with A ...... armacodynamics with almorexant
@nl
prefLabel
Entry-into-humans study with A ...... armacodynamics with almorexant
@ast
Entry-into-humans study with A ...... armacodynamics with almorexant
@en
Entry-into-humans study with A ...... armacodynamics with almorexant
@nl
P2093
P2860
P356
P1476
Entry-into-humans study with A ...... armacodynamics with almorexant
@en
P2093
Jasper Dingemanse
Joop van Gerven
Matthias Hoch
P2860
P304
P356
10.1002/JCPH.297
P407
P577
2014-04-21T00:00:00Z